SREBP1 (Sterol Regulatory Element-Binding Protein 1) is a family of transcription factors that serve as master regulators of lipid metabolism in mammalian cells[1]. The SREBP1 gene (SREBF1) produces two isoforms through alternative promoter usage: SREBP-1a and SREBP-1c, which have distinct but overlapping functions in regulating cholesterol, fatty acid, and triglyceride synthesis[2]. SREBP1 is synthesized as an inactive precursor bound to the endoplasmic reticulum membrane and undergoes proteolytic cleavage to release the active transcription factor that translocates to the nucleus[3]. In the brain, SREBP1 plays critical roles in neuronal lipid metabolism, myelin synthesis, and has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer's and Parkinson's disease[4].
The SREBP1 protein has a unique structure as a transcription factor requiring membrane anchoring for regulation:
| Isoform | Amino Acids | Primary Function |
|---|---|---|
| SREBP-1a | 1124 aa | Strong activator of cholesterol and fatty acid synthesis |
| SREBP-1c | 906 aa | Predominantly activates fatty acid synthesis |
| SREBP-1a ΔN (isoform) | ~900 aa | N-terminally truncated, constitutively active |
SREBP1 Protein Structure
┌─────────────────────────────────────────────────────────────────────┐
│ Activation │ bHLH-LZ │ Anchor │ Sterol-Sensing │ C-terminal│
│ Domain │ (DBD) │ │ Domain (SSD) │ │
│ (1-320) │(321-420) │ (421-500) │ (500-800) │(801-1124) │
└─────────────────────────────────────────────────────────────────────┘
bHLH-LZ: basic-helix-loop-helix-leucine zipper DNA-binding domain
SSD: Sterol-sensing domain (shared with NPC1, HMG-CoA reductase)
SREBP1 is the central regulator of lipogenesis:
Cholesterol Synthesis:
Fatty Acid Biosynthesis:
Triglyceride Synthesis:
SREBP1 Activation (Low Sterols)
┌──────────────────────────────────────────────┐
│ Endoplasmic Reticulum │
│ │
│ SREBP1 ──► Precursor (125 kDa) │
│ │ │
│ └───► Complex with SCAP │
│ (Sterol Accelerator Protein) │
│ │ │
│ Vesicle formation │
│ │ │
│ Transport to Golgi │
│ │ │
│ Site-1 protease (S1P) cleavage │
│ │ │
│ Site-2 protease (S2P) cleavage │
│ │ │
│ Active fragment (68 kDa) │
│ Nuclear translocation │
└──────────────────────────────────────────────┘
Key SREBP1 target genes include:
SREBP1 dysfunction is intimately connected to AD pathogenesis:
Cholesterol Metabolism:
Fatty Acid Metabolism:
Amyloid Processing:
Therapeutic Implications:
SREBP1 plays complex roles in PD:
Dopaminergic Neuron Metabolism:
Neuroinflammation:
Potential Targets:
| Gene Variant | Effect | Disease Association |
|---|---|---|
| SREBF1 variants | Altered regulation | AD risk |
| SREBP1 expression | Modified lipogenesis | PD progression |
| HMGCR variants | Cholesterol synthesis | Neurodegeneration |
| Partner | Interaction | Function |
|---|---|---|
| SCAP | Direct binding | Sterol sensing, ER retention |
| INSIG | ER retention protein | Inhibits transport |
| S1P/S2P | Proteolysis | Activation cleavage |
| p300/CBP | Coactivators | Transcriptional activation |
| NCoR | Corepressor | Transcriptional repression |
Fatostatin: Blocks SREBP processing
Betulin: SREBP1 inhibitor
Fatty Acid Synthase Inhibitors:
Brown et al. SREBP in cholesterol regulation (2000). 2000. ↩︎
Horton et al. SREBP isoforms (2002). 2002. ↩︎
Sato et al. SREBP cleavage and activation (2010). 2010. ↩︎
Lane et al. SREBP in neurodegenerative diseases (2018). 2018. ↩︎
Wang et al. SREBP1 in AD brain (2019). 2019. ↩︎